Bioactive O^N^O^ Schiff base appended homoleptic titanium(IV) complexes: DFT, BSA/CT-DNA interactions, molecular docking and antitumor activity against HeLa and A549 cell lines

Sathish Thanigachalam,Madhvesh Pathak
DOI: https://doi.org/10.1039/d3ra08574k
IF: 4.036
2024-04-23
RSC Advances
Abstract:Five new homoleptic derivatives of titanium( IV ) have been developed and characterized by physicochemical techniques. Metal complexes, TiH 2 L 1 [(C 38 H 26 N 6 O 4 )Ti], TiH 2 L 2 [(C 38 H 24 F 2 N 6 O 4 )Ti], TiH 2 L 3 [(C 38 H 24 Cl 2 N 6 O 4 )Ti], TiH 2 L 4 [(C 38 H 24 Br 2 N 6 O 4 )Ti] and TiH 2 L 5 [(C 38 H 24 N 8 O 8 )Ti], were obtained by treating Ti(OPr i ) 4 with appropriate ONO ligands (H 2 L 1 –H 2 L 5 ) in anhydrous THF as solvent. The electronic structures and properties of titanium( IV ) complexes ( TiH 2 L 1 –TiH 2 L 5 ) and ligands (H 2 L 1 –H 2 L 5 ) were examined by DFT studies. The stability of all synthesized derivatives was assessed by a UV-visible technique using 10% DMSO, GSH medium and n -octanol/water systems. The binding interactions of BSA and CT-DNA with respective titanium( IV ) complexes were successfully evaluated by employing UV-visible absorption, fluorescence, circular dichroism (CD) techniques and docking studies. The in vitro cytotoxicity of TiH 2 L 2 , TiH 2 L 3 and TiH 2 L 4 complexes was assessed against HeLa (human epithelioid cervical cancer cells) and A549 (lung carcinoma) cell lines. The IC 50 values of TiH 2 L 2 , TiH 2 L 3 and TiH 2 L 4 were observed to be 28.8, 14.7 and 31.2 μg mL −1 for the HeLa cell line and 38.2, 32.9 and 67.78 μg mL −1 for A549 cells, respectively. Complex TiH 2 L 3 exhibited remarkably induced cell cycle arrest in the G 1 phase and 77.99% ROS production selectivity in the HeLa cell line.
chemistry, multidisciplinary
What problem does this paper attempt to address?